This 340-page report contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market. Read more: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-point-of-care-poc-lipid-testing-supplier-shares-and-country-forecasts-market
Visit at: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-us-point-of-care-poc-infectious-disease-testing-supplier-shares-and-country-forecasts-market Research Beam’s report on 2015-2019 Future Horizons and Growth Strategies in the US Point-of-Care/POC Infectious Disease Testing Market: Supplier Shares and Country Forecasts” contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
iGATE Research has released a research report on “Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025” Click here to view the complete report: www.igateresearch.com Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
Point of care molecular diagnostics market is expected to reach a market value of USD 5.12 billion by 2027 growing at a CAGR of 12.9% in the forecast period of 2020-2027. The growing awareness regarding the testing methods among patients has been directly impacting the growth of point of care molecular diagnostics market.
This TriMark Publications report “Point of Care Diagnostic Testing World Markets” describes latest developments in the point of care testing market segment. For more details : http://goo.gl/6pZ2p8
Point-of-care coagulation testing devices market is projected to expand at a CAGR of ~6% during the forecast period, leading players in the market focus on new products with multiple modes and features, which will be more efficient and deliver a new level.
Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
The Report on “Point of Care POC Testing Market Size, Share, Growth, Profit, Analysis, Trends and Strategy 2015" added by Research Beam Enquiry about report: http://www.researchbeam.com/2015-emerging-point-of-care-poc-testing-cancer-clinics-ambulatory-centers-surgery-centers-nursing-homes-birth-centers-supplier-shares-volume-and-sales-forecasts-for-300-tests-market/enquire-about-report
Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
Infectious Diagnostics Rapid & Point of Care Tests Pipeline Review, 2015 provides an overview of Infectious Diagnostics Rapid & Point of Care Tests currently in pipeline stage. Enquiry about report: http://www.researchbeam.com/infectious-diagnostics-rapid-and-point-of-care-tests-pipeline-review-2015-market/enquire-about-report
Access full Research: https://www.renub.com/point-of-care-testing-market-and-forecast-to-2016-global-analysis-158-p.php Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024 experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry.
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
Global Point of Care Technology Market Information by Product Type (Glucose Testing, Cardiac Markers, Hb1Ac Testing, Coagulation), by Instrument (Blood Glucose Meter), by End User (Clinics, Hospital, Home Care, Ambulatory Care) - Forecast to 2027
Visit: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-us-point-of-care-poc-hematology-and-flow-cytometry-supplier-shares-and-country-forecasts-market Research Beam provides report on Future Horizons and Growth Strategies in the US Point-of-Care/POC Hematology and Flow Cytometry Markets 2015-2019, a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
Gastrointestinal parasites are not just essential pollution specialists in friend creatures, some are also irresistible to individuals. Of the by and large gigantic number of illustrative frameworks used to recognize gastrointestinal parasites, none is more unequivocal and solid than diffusive fecal flotation when it is performed fittingly. Fecal flotation is a standard veterinary test used to look at interior parasites or “worms.”
The molecular point of care diagnostics market is estimated to grow at a CAGR of 14.05% and expected to reach $7398.82 million by 2028. Get a Free Sample Report.
The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period. Cardiac biomarkers or cardiac markers are endogenous substances which are released in the blood stream when the heart is damaged or stressed. The acute coronary syndrome is caused by a plaque formed due to atherosclerosis, which causes thrombus formation in the damaged coronary artery and results in a sudden decrease in the amount of blood and oxygen which reaches the heart. Angina is due to the reduced blood supply in the heart, and when such blood flow is interrupted for 30-60 min, it can cause necrosis of heart muscle, resulting in myocardial infarction. Full Report: https://www.kbvresearch.com/cardiac-biomarkers-testing-market/
Point-of-care Cholesterol Monitoring Device Market: Inclination Towards Portable Devices & Increasing Cholesterol Home Testing Trending the Global Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
Veterinary Point of Care Blood Gas Analyzers Market is estimated to reach $66 million by 2023, growing at a CAGR of 4.9% during the forecast period. Full report: https://kbvresearch.com/veterinary-point-of-care-blood-gas-analyzers-market/
A recent report published by TheBusinessResearchCompany on Point-of-Care Diagnostics Devices And Equipment Market provides in-depth analysis of segments and sub-segments in the global as well as regional. http://bit.ly/2SsaM53
The research study on Global Veterinary Test kits Systems Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024 by DecisionDatabases.com analyses the complete value chain of the Industry. https://www.decisiondatabases.com/ip/39037-veterinary-test-kits-market-analysis-report
Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive.
A latest research report “Home Health Care And Residential Nursing Care Services Global Market Report” proposed by The Business Research Company provides a market summary on Market Analysis, Size, Trends and Growth. Read Full Report @ http://bit.ly/2XMvmfM Get Free Sample Copy @ http://bit.ly/2PzMtyA
Global Point of Care Diagnostics (POC) Market Analysis By Product, By Application, And Segment Forecasts To 2020 is a latest Medical Devices Industry report.
A new market study based on the Point Of Care Diagnostics Market designed from various sources which also include porter's five forces analysis research techniques to explore the new opening of the market for the period of 2019-2025. The study also interrogates and examines the information based on share, market size, growth path, and the latest trends to recognize the potential value of the market. And most importantly, the data on the current business scenario will also help players to understand the stakeholder strategies and discover the new opportunities which will help them to succeed in their way.
North America was the largest region in the home health care and residential nursing care services market in 2017, accounting for above 41% market share. The USA was the largest country in the market in 2017, accounting for above 36% market share. Read Report https://www.thebusinessresearchcompany.com/report/home-health-care-and-residential-nursing-care-services-global-market-report-2018
Intra-Dialytic Hypotension (IDH) Market : The IDH market is segmented based on location of testing, type of testing devices, and geography. Based on the type of testing devices, the market is further segmented into hospital testing devices and point-of-care (PoC) devices. Point-of-care (PoC) devices are beneficial for patients as they monitor inter- as well as intra-dialytic hypotension episodes. Currently, hospitals perform a majority of tests and would continue to hold a larger market share. Report Details@ http://www.bigmarketresearch.com/intra-dialytic-hypotension-IDH-market
Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories.
Allied Market Research has recently published a report on the point of care diagnostics market, which is a comprehensive study of the entire industry for the period of 2014–2022.
Global Ultrasound Devices Market accounted to USD 7 billion in 2018 to an estimated value of USD 9.3 billion by 2026 growing at a CAGR of 4.5% during the forecast period of 2019 to 2026. The upcoming market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
For more Info: https://www.renub.com/point-of-care-testing-market-nd.php Point of care testing (POCT), also known as bedside testing is a medical diagnostic testing that allows patient diagnoses on the field, in the ambulance, at the physician’s office, in the hospital, or at home. The results of the point of care testing are timely and accurate which allow rapid treatment to the patient. Point of care testing has the potential to widely impact the health care delivery system by addressing the challenges of health disparities in real time. The success of the potential shift from remedial medicine to modified, prognostic and preventive medicine could rely on the enhancement of portable monitoring and diagnostic devices for point of care testing. Point of Care Testing Market is projected to reach US$ 36 Billion by the end of year 2024.
The Point of Care Diagnostic Devices Market has changed the game because earlier, a medical sample had to be sent away from the patient for hours, sometimes for days, before the results were known. During this delay, the patient has to be treated without the necessary information.
Global Microfluidic Devices Market is estimated to reach $14.3 Billion by 2024; growing at a CAGR of 22.5% from 2016 to 2024. Microfluidic involves flow of liquid within micro-sized channels.
[452 Pages Report] Point-Of-Care Diagnostics / Testing Market report categories the Global market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
The rising incidence of infectious diseases and shift in focus from centralized laboratories to decentralized (POC) point-of-care testing is driving the market demand.
The Global Orthopedic Software Market size is expected to reach $396 Million by 2025, rising at a market growth of 6.3% CAGR during the forecast period. Orthopedic software manages a large amount of data from the reports of the laboratory test, such as imaging during diagnosis and for follow up charts of patients during recovery. It has become a standard practice for orthopedic surgeons to manage a large number of laboratory test results, particularly when it comes to diagnostic imaging. In short, orthopedic software like an EHR is used in the orthopedic point of care. The industry provides a wide range of orthopedic software products. The range includes orthopedic EHR, digital templating/preoperative planning software, orthopedic practice management, orthopedic RCM, orthopedic PACS, and many others. Full Report: https://www.kbvresearch.com/orthopedic-software-market/
Bharat Book Present"Coagulation Diagnostic Testing Market" which encompasses both laboratory and point of care (POC) testing, will continue to be one of the most important segments of the in vitro diagnostics market for the foreseeable future.
Major Players in the Blood Glucose Test Strips Market are F. Hoffmann-La Roche AG, LifeScan, Inc., Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Terumo Corporation Read more @ https://bit.ly/2RJEiW7
Major players in the remdesivir market are Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Cipla, Pfizer Read more @ https://bit.ly/2WmAp8k
The Global Biosensors Market size is expected to reach $34.3 billion by 2025, rising at a market growth of 8.6% CAGR during the forecast period. Biosensors are devices which combine biological components for detecting an analyte and a physicochemical component in order to produce a measurable signal. Currently, the most common biosensors are home pregnancy tests and glucose detectors. There is however, a drive to produce novel biosensor technologies for several applications like food analysis, deoxyribonucleic acid testing, and drug detection. Thin films make these sensors increasingly small and with fewer detection limits. Full Report: https://www.kbvresearch.com/biosensors-market/
As per FMI’s analysis, the following players operate within the global zika virus testing market: EUROIMMUN US Inc. Creative Diagnostics Quest Diagnostics Artron Laboratories Inc. RapiGEN Inc.
The major players covered in the global Poc Hba1C Testing Market are Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Menarini Group, F. Hoffmann-La Roche Ltd., ARKRAY Inc... @ @ https://bit.ly/3vBeLNy
A recent report published by The Business Research Company on Diabetes Care Devices Market provides in-depth analysis of segments and sub-segments in the global as well as regional.
Big Market Research has announced a new Report Package "World Factor Assays Testing Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/2015-world-factor-assays-testing-ambulatory-centers-commercial-labs-hospitals-physician-offices-poc-point-of-care-locations-competitive-landscape-country-segment-forecasts-innovative-technologies-inst-market The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more standardized, offering opportunities for quality control products and services. Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/330942
The major players covered in the global diabetes care devices market are Roche, Medtronic, J&J, Abbott, Becton, Dickinson and Company.... @ http://bit.ly/3pFquYr